Achondroplasia Treatment Market By Product type ( RBM-007, TA-46, B-701 ), By End-user ( Hospital, Clinics ), Industry Trends, Estimation & Forecast, 2017 - 2025

April 2018

 Pages: 168

 ERC 8188

Achondroplasia Treatment Market is expected to grow with a CAGR of XX% during the forecast period of 2018 to 2025.

Achondroplasia is a genetic disorder caused due to heredity or mutation of FGFR3 genes during sperm or egg development. It is also known as achondroplastic dwarfism as people suffering from it are abnormally short. Every 1 individual out of 25,000 births is affected by achondroplasia. At present, there is no prevention nor cure for achondroplastic dwarfism, due to which, the treatment is majorly focused on minimizing the complications such as sleep apnea, obesity, and arthritis. Research studies are focusing on the mutational changes occurring in the FGFR3 gene in order to identify the exact cause of achondroplasia and introduce a cure for it. The rising incidences of achondroplastic dwarfism with no cure or prevention remedies is expected to fuel the global market of achondroplasia treatment. Growth hormone therapy is an effective treatment for achondroplasia for only a short duration of time. The therapy has proved to be effective in growing the beneficial bones but only until the first and second year of the therapy. Such short duration effectiveness of GH therapy and the lack of awareness regarding achondroplastic dwarfism are expected to negatively influence the market growth.

The report provides detailed qualitative and quantitative analysis of the global achondroplasia treatment market. Market size and forecast in terms of value and volume has been provided for the period - (2017 - 2025), for the segments namely product type, and end-user in each of the major regions of the world.

Global Achondroplasia Treatment Market Player Analysis -

The report presents detailed analysis of major players operating in global Achondroplasia Treatment market. Few of them include Ribomic Inc., Ascendis Pharma A/S, BioMarin Pharmaceutical Inc. Detailed coverage on these market players with information on their revenue from achondroplasia treatment business, market share, gross margin and their growth strategies have been provided in the report.

Market Segmentation

Global achondroplasia treatment market is segmented on the basis of product type, end-user, and geography. On the basis of product type, the market is categorized into RBM-007, TA-46, B-701, and others. By end-user, the market is segmented into hospital, clinic, and others. Geographical coverage has been provided for each of the major regions including North America, Europe, Asia-Pacific, South America and Rest of the World.

Achondroplasia Treatment Market Segmentation

By Product type
   • RBM-007
   • TA-46
   • B-701
   • Others

By End-user
   • Hospital
   • Clinic
   • Others

By Geography
   • North America
            o U.S.
            o Canada
            o Mexico
   • Europe
            o U.K
            o France
            o Germany
            o Italy
            o Spain
            o Rest of Europe
   • Asia-Pacific
            o China
            o Japan
            o India
            o Korea
            o Rest of APAC
   • South America
            o Brazil
            o Rest of South America
   • Rest of the World
            o Middle East
            o Africa

Achondroplasia Treatment Market Key Players

• Ribomic Inc
• Ascendis Pharma A/S
• BioMarin Pharmaceutical Inc

Please fill in the form below to Request for Customized Report
  
Your personal details are safe and secured with us. Privacy Policy

To request sample copy of this report, please complete the form below verified and secure

We offer 10% free customization including country-level data, niche applications and competitive landscape with every report. This also includes a 30 minute free analyst discussion post report purchase.

  
Your personal details are safe and secured with us. Privacy Policy

    What Information does this report contain?

    • What was the market size of the Achondroplasia Treatment Market in 2017 and the expected market size by 2025, along with the growth rate?
    • An in-depth analysis of the current impacting factors, opportunities and challenges/restraints in the market
    • Which are the largest revenue generating products, services or regions and their comparative growth rate?
    • Which technology is in trend and how would it evolve during the forecast period (2017 - 2025)?
    • Which are the leading companies in the Achondroplasia Treatment Market and their competitive positioning basis their market share, product portfolio, strategic attempts and business focus?


Purchase Options





Offers & Discounts

  • Chapter purchase
  • Historical market data
  • Country level data breakdown
  • Free customization*
  • Discounts for first time
  • Special pricing for
              non-business entities

Customize

  • We offer 20% free customization on every purchase.

Get in touch!

  +91-844-601-6060


  help@esticastresearch.com